Dr. Answer AI for prostate cancer: Intention to use, expected effects, performance, and concerns of urologists.

Journal: Prostate international
Published Date: Nov 23, 2021

Abstract

OBJECTIVES: To efficiently implement artificial intelligence (AI) software for medical applications, it is crucial to understand the acceptance, expected effects, expected performance, and concerns of software users. In this study, we examine the acceptance and expectation of the Dr. Answer AI software for prostate cancer.

Authors

  • Mi Jung Rho
    College of Health Science, Dankook University, Cheonan-si, Korea.
  • Jihwan Park
    School of Software Convergence, College of Software Convergence, Dankook University, Korea.
  • Hyong Woo Moon
    Department of Urology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.
  • Choung-Soo Kim
    Department of Urology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
  • Seong Soo Jeon
    Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Minyong Kang
    Department of Urology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
  • Ji Youl Lee
    Department of Urology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

Keywords

No keywords available for this article.

External Resources

Popular Topics
Recent Journals